Phil is an equity research analyst most recently with S&P Capital IQ, where his stockpicking was recognized three times by the Wall Street Journal’s “Best on the Street” in healthcare, including the number one position in 2011, and on the Bloomberg terminal as a leading analyst covering the medical device and managed health care industries. He also covered consumer and industrial stocks, and co-led a special publication that highlighted underfollowed stocks that then outperformed. He occasionally consults and is on the board and finance committee of a not-for-profit. He holds an MBA in Finance from New York University.